Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Nordic Nanovector ASA: Invitation to Second Half and Full Year 2022 Results Presentation and Webcast
2023-02-21 11:00:10
Oslo, Norway, 21 February 2023
Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for
the second half and full year 2022 on Tuesday, 28 February 2023.
A presentation by Nordic Nanovector's interim CEO & CFO, Ludvik Sandnes, will be
held in-person and webcast live beginning at 8:30am CET.
VENUE: ADVOKATFIRMAET CLP DA, Sommerrogata 13, 0255 Oslo
Questions can be submitted in advance to ir@nordicnanovector.com
The webcast can be accessed from www.nordicnanovector.com in the section:
Investors & Media and a recording will also be available on this page after the
event.
The results report and the presentation will be available at
www.nordicnanovector.com in the section: Investors & Media/Reports and
Presentation/Interim Reports/2022 from 7:00am CET the same day.
IR enquiries
Ludvik Sandnes, Interim CEO & CFO
+47 907 43 017
ir@nordicnanovector.com
About Nordic Nanovector
Nordic Nanovector is committed to develop and deliver innovative therapies to
patients to address major unmet medical needs and advance cancer care.
Further information can be found at
www.nordicnanovector.com (https://nam10.safelinks.protection.outlook.com/?url=ht
t
p%3A%2F%2Fwww.nordicnanovector.com%2F&data=05%7C01%7Cmark.swallow%40medistrava.c
o
m%7C0b5d55887fcc4bddd24108db03d8d2c1%7C5c24475f929349d0b4e1ba6d190e92f9%7C0%7C0%
7
C638108002017583559%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIi
L
CJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=8ttx4sNkxIXKbRtEA7RQp%2FvHln
2
4QCaKkOEaehniofM%3D&reserved=0)
This information is subject to a duty of disclosure pursuant to Sections 4-2 and
5-12 of the Securities Trading Act.